Alexion Pharmaceuticals Technical Analysis

Alexion Pharmaceuticals Inc -- USA Stock  

USD 143.16  2.32  1.65%

Alexion Pharmaceuticals Inc shows Mean Deviation of 0.7953 and Risk Adjusted Performance of 0.0062. Alexion Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Alexion Pharmaceuticals Inc which can be compared to its rivals. Please confirm Alexion Pharmaceuticals Standard Deviation as well as the relationship between Maximum Drawdown and Expected Short fall to decide if Alexion Pharmaceuticals is priced correctly providing market reflects its regular price of 143.16 per share. Given that Alexion Pharmaceuticals has Jensen Alpha of (0.19), we suggest you validate Alexion Pharmaceuticals Inc prevailing market performance to make sure the company can sustain itself at future point.
Investment Horizon     30 Days    Login   to change

Alexion Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Alexion Pharmaceuticals Inc. You can use it to identify possible trend reversals for Alexion Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Alexion Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Alexion Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Alexion Pharmaceuticals Inc applied against its price change over selected period. The best fit line has a slop of 0.18 % which means Alexion Pharmaceuticals Inc will continue generating value for investors. It has 34 observation points and a regression sum of squares at 26.0, which is the sum of squared deviations for the predicted Alexion Pharmaceuticals price change compared to its average price change.

Did you try this?

Run Portfolio Reporting Now

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
Hide  View All  Next  Launch Portfolio Reporting
Alexion Pharmaceuticals Inc is rated fourth in mean deviation category among related companies. It is currently under evaluation in standard deviation category among related companies creating about  1.44  of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for Alexion Pharmaceuticals Inc is roughly  1.44